TQB2825

· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TQB2825, covering 2025-03-24 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma [Phase 1, Phase 2]

See pricing